Certara stock.

5.27 M Change from Last -18.62% Percent of Float 4.84% Research & Ratings Certara Inc. Per-Share Earnings, Actuals and Estimates Actual Analyst Range Consensus More View the latest Certara Inc....Certara Stock Prediction 2025. The Certara stock prediction for 2025 is currently $ 10.71, assuming that Certara shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -27.84% increase in the CERT stock price. Certara Stock Prediction 2030Get the latest information on Certara, Inc. (CERT) stock, including its performance, outlook, earnings, dividends, and insider transactions. See how CERT stock compares to other medical AI companies and the healthcare industry. Drayton Virkler CERT stock SEC Form 4 insiders trading. Drayton has made over 2 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Drayton exercised 3,990 units of CERT stock worth $57,536 on 31 March 2023.3,990 units of CERT stock worth $57,536 on 31 March 2023.

According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.

Companies Cryptocurrencies Technology Personal Finance More Earnings Financial Advisors Stocks CERT 0.47% Let’s Talk about Recently Listed Certara Stock …

Nasdaq | CERT U.S.: Nasdaq Certara Inc. Watch list NEW Set a price target alert After Hours Last Updated: Nov 24, 2023 2:28 p.m. EST Delayed quote $ 15.20 0.23 1.54% After Hours Volume: 2.55K... Certara stock has received a consensus rating of buy. The average rating score is and is based on 20 buy ratings, 10 hold ratings, and 0 sell ratings. What was the 52-week low for Certara stock?Mar 1, 2023 · Certara Reports Fourth Quarter and Full Year 2022 Financial Results. Annual Revenue Grows 17% on a Reported Basis and 20% at Constant Currency. PRINCETON, N.J.— March 1, 2023– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the fourth quarter and full year of 2022 and issued guidance ... Certara CERT has an Earnings ESP of +5.41% and sports a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here. Certara is set to report its first-quarter ...Nov 28, 2023 · CERT Stock Overview. Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. About the company. CERT fundamental analysis. Snowflake Score. Valuation. 1 /6. Future Growth.

Ms Sherman CERT stock SEC Form 4 insiders trading. Ms has made over 1 trades of the Certara stock since 2023, according to the Form 4 filled with the SEC. Most recently she exercised 3,990 units of CERT stock worth $50,194 on 31 March 2023.. The largest trade she's ever made was exercising 3,990 units of Certara stock on 31 March …

The average twelve-month price prediction for Palantir Technologies is $13.25 with a high price target of $25.00 and a low price target of $5.00. Learn more on PLTR's analyst rating history. Do Wall Street analysts like Palantir Technologies more than its competitors? Analysts like Palantir Technologies less than other Business Services …

Investors in Certara, Inc. CERT need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 17, 2023 $12.50 Call had some of the highest implied ...Exhibit 10.21 . CERTARA, INC. 2020 EMPLOYEE STOCK PURCHASE PLAN . 1. Purpose.The purpose of the Plan is to provide a means by which Eligible Employees may purchase Common Stock, thereby strengthening their commitment to the welfare of the Company and its Designated Companies and aligning their interests with those of the …Certara, Inc. (CERT) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.10 per share a year ago. These figures are ...Biosimulation can reduce the size of and cost of human trials, the most expensive and time-consuming part of drug development. In some cases, we can eliminate certain human trials completely. More than 2,000 customers worldwide choose us as their partner for biosimulation software and technology-driven services.The estimated Net Worth of William F Feehery is at least $78.7 Millón dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $45,530,211 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.Dec 1, 2023 · Certara stock has received a consensus rating of buy. The average rating score is and is based on 20 buy ratings, 10 hold ratings, and 0 sell ratings. What was the 52-week low for Certara stock? 110 Salaries (for 72 job titles) • Updated Nov 20, 2023. How much do Certara employees make? Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips. Our model gets smarter over time as more people share …

1.34%. $25.98M. Plains All American Pipeline L.P. 1.86%. $10.93B. TELL | Complete Tellurian Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.ClearBridge Investments highlighted stocks like Certara, Inc. (NASDAQ: CERT) in its Q3 2022 investor letter. Headquartered in Princeton, New Jersey, Certara, Inc. (NASDAQ:CERT) is a software ...Rajesh Krishna, PhD, is a Distinguished Scientist in Drug Development Science and lead of the integrated practice area on rare diseases at Certara Strategic Consulting. With ~25 years of combined pharmaceutical industry and consulting experience, he has contributed to over 40 INDs; over 200 Phase 1/1b studies; and to several …1.90%. $360.63M. Adtran Networks SE. 0.50%. €1.02B. CIEN | Complete Ciena Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Get the latest information on Certara, Inc. (CERT) stock, including its performance, outlook, earnings, dividends, and insider transactions. See how CERT stock compares to other medical AI companies and the healthcare industry.Complete Certara Inc. stock information by Barron's. View real-time CERT stock price and news, along with industry-best analysis. 7 Nov 2022 ... Certara shares soar after Arsenal buys back EQT's stake · Arsenal says it will acquire roughly 30 million shares at $15 per share, reflecting a ...

When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.

Why Certara. Responsibility. Certara is committed to understanding, monitoring, and managing our social and environmental responsibilities. Regulatory Adoption. Many global regulatory agencies have adopted use of Certara’s Simcyp PBPK and Phoenix PK/PD platforms. Locations. Discover our global office locations. LeadershipPRINCETON, N.J.—November 22, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public …11 Des 2020 ... The EQT-backed drug simulation software maker's shares jumped as much as 72% following the company's IPO.Nov 8, 2023 · Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock? The company had revenue of $85.58 million for the quarter, compared to analyst estimates of $85.96 million. Certara has generated ($0.21) earnings per share over the last year (($0.21) diluted earnings per share). Earnings for Certara are expected to decrease by -9.09% in the coming year, from $0.33 to $0.30 per share.Mar 1, 2023 · Certara, Inc. (CERT) delivered earnings and revenue surprises of 14.29% and 4.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Nov 28, 2023 · CERT Stock Overview. Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. About the company. CERT fundamental analysis. Snowflake Score. Valuation. 1 /6. Future Growth.

Certara CERT has an Earnings ESP of +5.41% and sports a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here. Certara is set to report its first-quarter ...

Certara, Inc. (NASDAQ:CERT), is not the largest company out there, but it received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US ...78.45. +1.10%. 26.59M. View today's Certara Inc stock price and latest CERT news and analysis. Create real-time notifications to follow any changes in the live stock price.PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8th, 2023. Company management will host a conference call to discuss financial results at 5:00PM ET.Open $0.9454. Day Range 0.9230 - 1.0100. 52 Week Range 0.7078 - 1.6300. Market Cap $454.63M. Shares Outstanding 399.78M. Public Float 370.52M. Beta 1.69. Rev. per Employee $3.692M. P/E Ratio N/A.Certara stock drops after biotech software company misses profit target. Certara Inc. CERT, -2.56% stock was down 14.6% in premarket trades on Thursday …Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Certara Inc have a median target of 19.00, with a high estimate of 21.00 and a low estimate of 16.00. The median estimate ...View Certara, Inc CERT investment & stock information. Get the latest Certara, Inc CERT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.November 15, 2021. PRINCETON, N.J.– November 15, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering by certain selling stockholders of 10 million shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission.Nov 30, 2023 · Overall, Nice Ltd (ADR) stock has a Value Score of 17, Growth Score of 97 and Quality Score of 94. Certara Inc stock has a Value Score of 14, Growth Score of 50 and Quality Score of 58. Comparing Nice Ltd (ADR) and Certara Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.

Nov 24, 2023 · Bank of Montreal Can purchased a new stake in shares of Certara, Inc. (NASDAQ:CERT – Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 10,490 shares of the company’s stock, valued at approximately $194,000. A number of other hedge funds and other institutional […] What is the support and resistance for Certara (CERT) stock price? CERT support price is $14.50 and resistance is $15.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CERT stock …We would like to show you a description here but the site won’t allow us.The high in the last 52 weeks of Certara stock was 24.95. According to the current price, Certara is 58.68% away from the 52-week high. What are analysts …Instagram:https://instagram. delorean motor companycash account vs margin account webullnucor stocksaapl buy or sell Dec 1, 2023 · Latest Software and Docebo Inc, Certara Inc Stock News. As of December 1, 2023, Docebo Inc had a $1.9 billion market capitalization, compared to the Software median of $398.3 million. Docebo Inc’s stock is NA in 2023, NA in the previous five trading days and up 41.82% in the past year. Currently, Docebo Inc does not have a price-earnings ratio. stock nvobest place to create an llc Arsenal closed the previously announced $449M stock purchase from funds controlled by EQT Private Equity. PRINCETON, N.J.— December 8, 2022 — Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in investing in and building transformational healthcare companies, …Certara is the leading provider of model-informed drug development technology and services, as well as a best-in-class provider of regulatory science, writing, and submission management software and services. Certara’s solutions help inform the drug development and regulatory approval process and address the key efficacy, safety, … crypocurrency brokers ETF Watch. Macquarie Introduces Its First U.S. ETFs. Gabe Alpert | Nov 30, 2023. Our CERT ETF report shows the ETFs with the most CERT exposure, the top performing CERT ETFs, and most popular CERT ...Certara Inc Ordinary Shares 700 Morningstar Rating Unlock Stock XBER Rating as of Nov 24, 2023 Summary Chart News Price vs Fair Value Sustainability …Nov 30, 2023 · Overall, Nice Ltd (ADR) stock has a Value Score of 17, Growth Score of 97 and Quality Score of 94. Certara Inc stock has a Value Score of 14, Growth Score of 50 and Quality Score of 58. Comparing Nice Ltd (ADR) and Certara Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.